UBS analyst Chris Snyder increased the price target on TE Connectivity (NYSE:TEL) shares to $188 from the previous $177, ...
Finally, Protagonist Therapeutics (NASDAQ:PTGX) has indicated that its financial runway extends beyond the fourth quarter of 2028, providing the company with a stable foundation to continue its ...
Reports Q1 revenue $468.5M, consensus $485.23M. “Our December quarter revenue and same-store sales performance reflected a combination of the ...
Q1 2025 Earnings Conference Call January 23, 2025 10:00 AM ETCompany ParticipantsScott Solomon - Investor Relations, ...
Everyone, thank you for standing by and welcome to the TE Connectivity first-quarter earnings call for fiscal year 2025. (Operator Instructions) And as a reminder, today's call is being recorded. I ...